Carla L. Coackley
Guelph, ON N1G2W1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Cardiolipin-Based Nanoparticles Inhibit α-Synuclein Fibrilization.
Journal: ACS chemical neuroscience
Published: December 26, 2025
G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesis.
Journal: Cell reports
Published: September 14, 2024
Intracellular Accumulation of α-Synuclein Aggregates Promotes S-Nitrosylation of MAP1A Leading to Decreased NMDAR-Evoked Calcium Influx and Loss of Mature Synaptic Spines.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: January 11, 2022
Partial magic angle spinning NMR 1H, 13C, 15N resonance assignments of the flexible regions of a monomeric alpha-synuclein: conformation of C-terminus in the lipid-bound and amyloid fibril states.
Journal: Biomolecular NMR assignments
Published: February 06, 2021
Docosahexanoic acid signals through the Nrf2-Nqo1 pathway to maintain redox balance and promote neurite outgrowth.
Journal: Molecular biology of the cell
Published: January 27, 2021
α-Synuclein mutation impairs processing of endomembrane compartments and promotes exocytosis and seeding of α-synuclein pathology.
Journal: Cell reports
Published: February 15, 2020
Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 26, 2019
Cardiolipin exposure on the outer mitochondrial membrane modulates α-synuclein.
Journal: Nature communications
Published: January 20, 2017
In vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: An exploration of the therapeutic ratio.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 08, 2015
PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 25, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026